Ayhan BOZKURT, Süleyman SIRRI BİLGE, Sibel BARIŞ, Deniz KARAKAYA, Bilge CAN, Ersin KÖKSAL, Yasemin Burcu ÜSTÜN

Intracerebroventricular Application of Dexmedetomidine Produces Antinociception and Does not Cause Neurotoxicity in Rats

Background: Alpha2 agonists contribute to pain control at the level of the medulla spinalis. Alpha2 agonists are generally added to local anaesthetics to prolong spinal or epidural anaesthesia time. Aims: In the present study, we aimed to evaluate the antinociceptive and neurotoxic effects of dexmedetomidine given intracerebroventricularly for 5 days. Study Design: Animal experimentation. Methods: After intraventricular cannulation, rats (n=32) were divided into two groups (n=16 each). Rats in the dexmedetomidine group (Group D, n=16) received 3 µg (0.03 mL) dexmedetomidine and the control group (Group C, n=16) received 0.03 mL physiological serum through an intracerebroventricular catheter once a day, for 5 days. Antinociceptive, sedative, and motor effects were evaluated before the injection and for 90 min after injection. The tail-flick and hot plate tests were used to assess thermal nociceptive threshold. For histopathological evaluation, half of the rats in both groups were sacrificed on the 6th day and the remaining rats were sacrificed on the 21st day. Then the perfusion fixation method was applied. The first tissue section was obtained from the cervical spinal cord 1 cm distal to the proximal end of the spinal cord. The second sample was retrieved from the region 1 cm distal from the thoracic 13-lumbar 1 vertebra. On morphological evaluation, nonspecific changes like edema and gliosis, signs of neuronal degeneration demonstrating a severe reaction, and density of inflammatory cells were examined. Results: In dexmedetomidine-administered rats, on the first day reaction times at 5, 10, and 20 min and on the other days, reaction times at 5, 10, 20, and 30 min in hot plate tests were significantly longer compared with baseline values (p

PDF

___

1. Jones SL, Gebhart GF. Characterization of coeruleospinal inhibition of the nociceptive tail-flick reflex in the rat: mediation by spinal alpha 2-adrenoceptors. Brain Res 1986;364:315-30. [CrossRef]
2. D’Angelo R. Should we administer epidural or spinal clonidine during labor? Reg Anesth Pain Med 2000;25:3-4. [CrossRef]
3. Mercier FJ, Boulay G, Ber Ayed M, Benhamou D. Combined spinal and epidural analgesia for labor. Prolongation by the addition of a minidose of clonidine to sufentanil. An initial study. Ann Fr Anesth Reanim 1996;15:263-5. [CrossRef]
4. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999;54:146-165. [CrossRef]
5. Lakhlani PP, MacMillan LB, Guo TZ. Substitution of a mutant alpha2 adrenergic receptor via ‘’hit and run’’ gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci 1997;94:9950-5. [CrossRef]
6. Yaksh TL. Pharmacology of spinal noradrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985;22:845-58. [CrossRef]
7. Stevens CW, Brenner GM. Spinal administration of adrenergic agents produces analgesia in amphibians. Eur J Pharmacol 1996;316:205-10. [CrossRef]
8. Loo CC, Dahlgren G, Irestedt L. Neurological complications in obstetric regional anaesthesia. Int J Obstet Anesth 2000;9:99- 124. [CrossRef]
9. Horlocker TT, Wedel DJ. Neurologic complications of spinal and epidural anesthesia. Reg Anesth Pain Med 2000;25:83-98. [CrossRef]
10. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, 4th edition. San Diego, Academic Press, 1998, pp 19-66.
11. Eddy Nb, Leimbach D. Synthetic Analgesics. II. Dithienylbutenyl and Dithienylbutylamines. J Pharmacol Exp Ther 1953;107:385-93.
12. D’Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941;72:74-79.
13. Archer DP, Lamberty Y, Wang B, Davis MJ, Samanani N, Roth SH. Levetiracetam reduces anesthetic-induced hyperalgesia in rats. Anesth Analg 2007;104:180-5.[CrossRef]
14. Yamamoto T, Nozaki-Taguchi N, Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol 2002;137:170-6. [CrossRef]
15. Koizumi Y, Matsumoto M, Yamashita A, Tsuruta S, Ohtake T, Sakabe T. The effects of an AMPA receptor antagonist on the neurotoxicity of tetracaine intrathecally administered in rabbits. Anesth Analg 2006;102:930-6. [CrossRef]
16. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605. [CrossRef]
17. Eisenach JC, De Kock M, Klimscha W. Alpha2 adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984- 1995). Anesthesiology 1996;85:655-74. [CrossRef]
18. Fisher B, Zornow MH, Yaksh TL, Peterson BM. Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur J Pharmacol 1991;192:221-5. [CrossRef]
19. Joo G, Horvath G, Klimscha W, Kekesi G, Dobos I, Szikszay M, et al. The effects of ketamine and its enantiomers on the morphine or dexmedetomidine-induced antinociception after intrathecal administration in rats. Anesthesiology 2000;93:231-41. [CrossRef]
20. Kalso EA, Pöyhia R, Rosenberg PH. Spinal antinociception by dexmedetomidine, a highyl selective α2-adrenergic agonist. Pharmacol Toxicol 1991;68:140-3. [CrossRef]
21. Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, Al-Yaman R, et al. Effect of low dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand 2006;50:222-7. [CrossRef]
22. Al-Mustafa MM, Abu-Halaweh SA, Aloweidi AS, Murshidi MM, Ammari BA, Awwad ZM, et al. Effect of dexmedetomidine added to spinal bupivacaine for urological procedures. Saudi Med J 2009;30:365-70.
23. Mohamed AA, Fares KM, Mohamed SA. Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician 2012;15:339-48.
24. Xiang Q, Huang DY, Zhao YL, Wang GH, Liu YX, Zhong L, et al. Caudal dexmedetomidine combined with bupivacaine inhibit the response to hernia sac traction in children undergoing inguinal hernia repair. Br J Anaesth 2013;110:420-4. [CrossRef]
25. Espejo EF, Mir D. Structure of the rat’s behaviour in the hot plate test. Behav Brain Res 1993;56:171-6. [CrossRef]
26. Talke PO, Caldwell JE, Richardson CA, Kirkegaard-Nielsen H, Stafford M. The effects of dexmedetomidine on neuromuscular blockade in human volunteers. Anesth Analg 1999;88:633-9. [CrossRef]
27. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive car. Br J Anaesth 2002;88:669-75. [CrossRef]
28. Buerkle H, Yaksh TL. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat. Br J Anaesth 1998;81:208-15. [CrossRef]
29. Gordh T Jr, Post C, Olsson Y. Evaluation of the toxicity of subarachnoid clonidine, guanfacine and substance p-antagonist on rat spinal cord and nerve roots:Light and electron microscopic observations after chronic intrathecal administration. Anesth Analg 1986;65:1303-11. [CrossRef]
30. Gordh TE, Ekman S, Lagerstedt AS. Evaluation of possible spinal neurotoxicity of clonidine. Ups J Med Sci 1984;89:266-73. [CrossRef]
31. Konakci S, Adanir T, Yilmaz G, Rezanko T. The efficacy and neurotoxicity of dexmedetomidine administered via the epidural route. Eur J Anaesthesiol 2008;25:403-9. [CrossRef]
32. Tachibana K, Hashimoto T, Kato R, Uchida Y, Ito R, Takita K, et al. Neonatal administration with dexmedetomidine does not impair the rat hippocampal synaptic plasticity later in adulthood. Paediatr Anaesth 2012;22:713-9. [CrossRef]
33. Gul S, Hanci V, Bahadir B, Acikgoz S, Bektas S, Ankarali H, et al.The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats. J Clin Neurosci 2010;17:490-4. [CrossRef]
34. Zhu YM, Wang CC, Chen L, Qian LB, Ma LL, Yu J, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focalcerebral ischemia/reperfusion injury in rats. Brain Res 2013;1494:1-8. [CrossRef]
35. Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. Anesthesiology 2008;109:502-11. [CrossRef]